Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

MMJ Recs

MAY 9, 2024

As such, we provide you with a comprehensive guide for veterans using medical cannabis and the various aspects of it, including its usage, accessibility, legal considerations, healthcare options, and available resources. Navigating the complexities surrounding the Veterans Administration and medical cannabis can be daunting.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

The Cannigma

JUNE 4, 2023

Peru has undergone significant changes in its cannabis laws in recent years, reflecting a more progressive approach compared to many other countries. Patients with qualifying medical conditions can access cannabis-based products with a prescription from authorized healthcare professionals. Is it legal to grow weed in Peru?

Law 52

Law Seed-To-Sale Research and Development Cultivation 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

MAY 29, 2022

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms. A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

AUGUST 20, 2022

CRCC’s paper, published by the Ohio State University (OSU) Moritz College of Law, is titled “Not a SAFE Bet: Equitable Access to Cannabis Banking, An Analysis of the SAFE Banking Act.”. Ohio State Legal Studies Research Paper No. Ohio State Legal Studies Research Paper No. Drug Enforcement and Policy Center, August, 2022.

Banking 52

Banking Access Research and Development Policy 52

Cannabis Law Report

DECEMBER 5, 2021

Funders are endorsing MAPS’ mission and pursuit of mass mental health backed by 35 years of innovative leadership, governance, programs, and strategies. This model fully maintains both MAPS’ nonprofit mission and governance and MAPS Public Benefit Corporation ’s (MAPS PBC) public benefit drug development and post-approval activities.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Cannabis Law Report

MARCH 8, 2022

WORCESTER, MA— The Cannabis Control Commission (Commission) hosted a virtual orientation seminar on Thursday, March 3 for participants of the third cohort of Massachusetts’ first-in-the-nation Social Equity Program. Chairman Steven Hoffman and Social Equity Program Participant Aaron Goines then hosted a business planning seminar.

Programs 52

Programs Research and Development Access Business 52

MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. Rapidly growing research and personal reports suggest medical cannabis could be the answer.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JANUARY 31, 2022

(TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

JULY 1, 2022

We are currently recruiting for a Program Analyst to develop, coordinate, and analyze our tracking systems. The position will be developing and evaluating OPS’s Training program, Licensing and Compliance (TLC) system as well as OPS’s product tracking system. Research and recommend systems, policies, and operations.

Programs 52

Programs Compliance Compliance Research and Development 52

SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . This new program is being funded by private investors, including Matt Wullenweg, developer of WordPress, and philanthropist Tim Ferriss.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

JULY 13, 2022

WORCESTER, Mass. , July 13, 2022 /PRNewswire/ — Green Flower, a California -based education company focused on the cannabis industry, announced four new online certificate programs in partnership with Worcester Polytechnic Institute (WPI). The programs are now open for enrollment with classes starting on September 5.

Education 52

Education Programs Research and Development Agriculture 52

Cannabis Law Report

AUGUST 3, 2021

Puerto Rico’s Governor has signed legislation into law protecting qualified medical cannabis patients from workplace discrimination. The legislation amends Puerto Rico’s medical marijuana access law so that registered patients are now classified as members of a protected class under the US territory’s employment protection laws.

Patients 105

Patients Law Research and Development Medicine 105

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Additionally, stigma and misinformation surrounding medical marijuana persist, impacting public perception and patient access.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

MMJ Recs

FEBRUARY 10, 2024

The journey begins with early debates around the medicinal use of cannabis, leading to the eventual establishment of the state’s medical marijuana program. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.

Research and Development 105

Research and Development Marijuana History Legislation 105

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

SpeedWeed

JUNE 2, 2021

New Hampshire Governor Chris Sununu (R) just signed a bill to expand the list of qualifying conditions for the state’s medical marijuana program. Some clinical research studies have indeed found that occasional use of medical pot can help treat insomnia , but other studies have been less conclusive. View original article.

Conditions 52

Conditions Programs Research and Development Marijuana 52

Cannabis Law Report

JUNE 1, 2021

Under the agreement, Native Roots will establish a new tissue culture program at their flagship Denver facility leveraging FRB’s proprietary Clean Stock® platform. At launch, the program will be the first-of-its-kind in Colorado , a differentiating factor in an increasingly competitive market.

Programs 98

Programs Supply Chain Research and Development Hemp 98

Cannabis Law Report

JULY 8, 2021

The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It Medicinal Cannabis Research Collaboration (MCRC).

Medicine 98

Medicine Research and Development Safety THC 98

Cannabis Law Report

JUNE 17, 2021

goodblend™ Texas , a retail brand of Parallel , one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program. goodblend™ Texas, a retail brand of Parallel. “We

Patients 97

Patients Programs Sleep Retail 97

Americans for Safe Access

MAY 21, 2019

Americans for Safe Access Wants to Help You Navigate the Federal Regulatory Process. In 2018, the FDA solicited public comments to help determine the United States’ position on the rescheduling of CBD and other cannabis compounds under international law. This is not the first time that the FDA has called for comments.

Research and Development 149

Research and Development Policy Food Programs 149

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

NORML

FEBRUARY 15, 2020

New Approach Montana, the campaign committee behind a marijuana legalization ballot initiative in the state, submitted a revised proposal to the Secretary of State’s office, removing provisions that address medical marijuana law changes. Send a message to your lawmakers in support of medical marijuana access. AL resident?

Legislation 264

Legislation Decriminalization Access Patients 264

Cannabis Law Report

JULY 19, 2021

We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally. LMC Manna Research is also part of hyperCORE International, which has access to more than 100 award winning research sites across two continents making them the second largest clinical research site organization globally.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

The Cannigma

JUNE 19, 2022

The country has had a medical cannabis program since 2015. This change in law did not legalize the purchase or sale of cannabis, but it did remove a potential prison sentence of 64 months. Colombia’s medical cannabis program allows for research and product development, as well as prescriptions.

Legalization 97

Legalization Decriminalization Research and Development Consumption 97

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

APRIL 2, 2022

Founded in 2019, Roots to Thrive is Canada’s first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week group therapy programs that include psilocybin-assisted and ketamine-assisted group therapy sessions.

Therapy 52

Therapy Research and Development Programs Legalization 52

Cannabis Law Report

AUGUST 7, 2021

MAPS PBC catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics. We are currently focused on developing MDMA-assisted therapy as a Breakthrough Therapy for PTSD, with plans to submit for FDA approval in 2023. Key Responsibilities.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Cannabis Law Report

SEPTEMBER 10, 2021

The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. Clerkenwell Health is a psychedelic specialist clinical research organisation, based in the UK, backed with investment from VC Fund Vine Ventures, and Angel investors.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Cannabis Law Report

OCTOBER 28, 2021

The Government is backing a research and development programme to help accelerate the establishment of New Zealand’s medicinal cannabis industry and boost export potential. The NZ Herald reports. The Sustainable Food and Fibre Futures fund (SFF Futures) is contributing nearly $760,000 to the $1.9

Programs 52

Programs Research and Development Pharmaceutical Cultivation 52

The Cannigma

MARCH 14, 2023

Those who were already under close watch by law enforcement because of structural racism, as well as those who were responsible for the well being of others had to be very careful about how they were perceived by those in control of the laws. This included whether they had access to educational information about cannabis.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

JUNE 7, 2021

ETF, investors also have much easier access to the market. Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development.

Research and Development 98

Research and Development Clinical Trials Extraction Retail 98